BioRender Icon

Child 2 (gender-neutral, stage I obesity, anterior)

Child 2 (gender-neutral, stage I obesity, anterior) - Editable icon of a gender-neutral child with stage I obesity in an anterior anatomical position with East Asian facial features
[{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07d0/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07d0/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07d1/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07d1/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07d2/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07d2/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07d3/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07d3/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07d4/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07d4/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07d5/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07d5/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07d6/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07d6/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07d7/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07d7/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07d8/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07d8/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07d9/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07d9/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07da/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07da/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07db/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07db/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07dc/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07dc/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07dd/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07dd/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07de/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07de/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07df/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07df/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07e0/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07e0/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07e1/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07e1/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07e2/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07e2/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07e3/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07e3/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07e4/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07e4/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07e5/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07e5/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07e6/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07e6/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07e7/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07e7/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07e8/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07e8/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07e9/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07e9/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07ea/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07ea/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07eb/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07eb/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07ec/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07ec/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07ed/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07ed/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07ee/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07ee/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07ef/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07ef/671a99391adafe9ee12f079e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a995a1adafe9ee12f07f0/671a99391adafe9ee12f079e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a995a1adafe9ee12f07f0/671a99391adafe9ee12f079e.png"}]
Use This Icon – Free
No credit card required to sign up.

This icon is fully editable in BioRender

  • Add text, shapes, & other icons
  • Search 50,000+ scientifically accurate icons
  • Recolor and rearrange every icon, line, & label
  • Export or share for any use case
Scientist Avatars

Join 4M+ scientists already making publication-ready figures

Go from icons to finished figure – in minutes

  • Search from 50,000+ scientifically accurate, peer-reviewed icons
  • Customize with labels, shapes, and additional icons – everything is completely editable
  • Export or share your figures with collaborators
page dashboard

Not quite the right icon? Discover more.

Search 50,000+ icons across 30+ life-science fields.

search icon
arrow-right
Keywords
child,gender-neutral child,child gender neutral,gender-neutral,neutral,asexual,unsexed,sexless,male child,female child,boy child,girl child,boy,girl,young,young age,small child,children,kid,human child,minor,adolescent,preadolescence,preteen,preteenager,tween,tweenager,tweener,overweight,obese,obesity stage I,high BMI,excess weight,large,chubby,plus-sized,heavy,full-figured,above average weight,back,head,limbs,arm,leg,hand,foot,feet,anterior,frontal,front view,anterior view,front,nude,naked,without clothes,unclothed,human,human figure,figure,child development,development,puberty,pediatric,pediatrics,whole body,body,age,person,human anatomy,anatomy,East Asian,Asian,Oriental,light-skinned Asian,light-skin,fair complexion,Chinese,Japanese,Korean,Mongoloid,Southeast Asian,Pacific Islander,Asian-Pacific,Sino,24q2-content-refinement,24q2-content-refinement-human-figure-diversity,child
View More

Try a synonym, or sign up to request an icon from the app.

Image types

Child 2 (gender-neutral, stage I obesity, anterior) icon JPEG

Child 2 (gender-neutral, stage I obesity, anterior) icon PNG

Child 2 (gender-neutral, stage I obesity, anterior) icon SVG

Child 2 (gender-neutral, stage I obesity, anterior) icon GIF

Biorender Icon FAQs

How are scientists using the Child 2 (gender-neutral, stage I obesity, anterior) icon in their work?

BioRender users often use the Child 2 (gender-neutral, stage I obesity, anterior) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Human Anatomy.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Child 2 (gender-neutral, stage I obesity, anterior) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Child 2 (gender-neutral, stage I obesity, anterior) icon customizable in BioRender?

Most icons in BioRender, including the Child 2 (gender-neutral, stage I obesity, anterior) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Child 2 (gender-neutral, stage I obesity, anterior) icon for publication or presentations?

Yes, figures containing the Child 2 (gender-neutral, stage I obesity, anterior) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Child 2 (gender-neutral, stage I obesity, anterior) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Child 2 (gender-neutral, stage I obesity, anterior) icon — especially those focused on Human Anatomy. You can search BioRender’s template library or add this icon manually to any canvas.

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Child 2 (gender-neutral, stage I obesity, anterior) icon along with our library of more than 30,000 life science icons.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now
x icon